Nanomedicines Design: Approaches towards the Imaging and Therapy of Brain Tumours
Matthew Chapman and Sofia I. Pascu*
Chemistry Department, University of Bath, Claverton Down, Bath, UK
- *Corresponding Author:
- Sofia I Pascu
Chemistry Department University of Bath
Claverton Down Bath, UK
E-mail: [email protected]
Received Date: February 09, 2012; Accepted Date: March 08, 2012; Published Date: March 11, 2012
Citation: Chapman M, Pascu SI (2012) Nanomedicines Design: Approaches towards the Imaging and Therapy of Brain Tumours. J Nanomedic Nanotechnol S4:006. doi:10.4172/2157-7439.S4-006
Copyright: © 2012 Chapman M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Nanotechnology has potential to revolutionize diagnosis and therapy of diseases in the central nervous system through nanotheranostics. This simply states that a nanocarrier can be designed in an ‘all-in-one’ approach to facilitate both the functions of a diagnostic and a therapeutic drug. There are many challenges that must be overcome for these nanocarriers to become a successful design, but if resolved nanocarriers could pave the way for personalised medicine. This review highlights several new ideas behind nanotheranostics design and testing with a particular focus on cancerous tumours in the brain.